Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy

Inclusion Criteria: * CIPN as diagnosed by Oncology and/or neurology * Receipt of a platinum-based or taxane chemotherapy prior to development of CIPN * Pain severity greater than 4 out of 10 on a numeric rating scale of pain * Pain chronicity greater than 6 months after the cessation of chemotherapy * Failure of medical therapy, which must have included duloxetine * Age 18 or greater Exclusion Criteria: * Platelet count less than 100k/mm3 * Spinal anatomy precluding placement of the SCS leads between T6 and T11 * Active infection * Estimated Lifespan less than 1 year * Receipt of vincristine, thalidomide, bortezomib, or eribulin within the prior 12 months